Seoul, South Korea

Sun-Ho Choi

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Sun-Ho Choi

Introduction

Sun-Ho Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with antibacterial properties. With a total of five patents to his name, Choi's work has garnered attention for its potential impact on medical treatments.

Latest Patents

Choi's latest patents include a novel salt of (R)-(-methylpyrrolidine-3-yl)methyl(-chloro-4-fluoro-[1,1'-biphenyl]-2-yl)carbamate and its crystal form. This invention is notable for its remarkable stability, hygroscopicity, and solubility. Another significant patent involves tetrahydropyridine derivatives, which are designed as antibacterial agents. This patent outlines methods for preparing these compounds and their use in treating Gram-negative bacterial infections, showcasing their potential as therapeutic medicaments.

Career Highlights

Throughout his career, Sun-Ho Choi has worked with notable companies such as Dong-A ST Co., Ltd. and CJ CheilJedang Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Choi has collaborated with several professionals in his field, including Weon-Bin Im and Sung-Hak Choi. These collaborations have likely enhanced the quality and scope of his research and inventions.

Conclusion

Sun-Ho Choi's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments, particularly in combating bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…